FDA and FTC Issue Joint Warning Letter

On Tuesday, the FDA and FTC issued another joint Warning Letter to a company for selling and marketing “unapproved new drugs” containing CBD in violation of federal law. Not surprisingly, the letter cites numerous disease claims included in the marketing of these products (e.g., statements related to the treatment of Parkinson’s and Alzheimer’s Disease, depression,